Boston Scientific (NYSE:BSX) employees could see their annual bonus payments shrink or grow based on the device maker’s adjusted earnings per share and global sales by the end of the year, thanks to a new performance incentive plan for 2012.
The Natick, Mass.-based med-tech titan reconfigured its employee reward system, tying the total potential payout for all regions and division into a single pool, the value of which fluctuates along with the company’s performance in 2012.
Lumbar spine surgery company TranS1 Inc. (NSDQ:TSON) priced a public offering of 6.2 million shares of common stock at $3.25 per share, expecting to raise up to $20.2 million.
TranS1 plans to use the funds for additional clinical trials, reimbursement efforts, sales personnel, research and product development activities and working capital, according to SEC filings. It added that funds may go toward acquisition of or investment in technologies, products or assets that complement the business.
The FDA sent a warning letter to Non-Invasive Monitoring Systems Inc. (OTC:NIMU) alleging that the company markets its therapeutic vibrator for uses not approved by the federal watchdog agency.
The Miami, Fla.-based company’s Exer-Rest “whole body periodic acceleration system” is a Class I exempt device, according to the company, meaning it doesn’t need to undergo the pre-market studies required for 510(k) clearance or the more rigorous pre-market approval process for medical devices.